AL | AN | AN vs. AL | |
---|---|---|---|
Falciparum malaria | |||
Number | 92 | 94 | |
Anti-malarial treatment | 1.58 ± 0.56 | 12.04 ± 3.35 | 10.46 (9.77 to 11.16)* |
Paracetamol | 0.003 ± 0.002 | 0.003 ± 0.003 | 0.000 (− 0.001 to 0.001) |
Clinic visits | 5.53 ± 1.63 | 5.23 ± 0.77 | − 0.29 (− 0.66 to 0.08) |
Total (usual care) | 7.66 ± 2.29 | 17.28 ± 3.40 | 9.61 (8.78 to 10.45)* |
Excess costs for trial | 54.71 ± 1.31 | 49.56 ± 1.54 | − 5.15 (− 5.56 to − 4.74)* |
Total (trial) | 62.37 ± 3.21 | 66.84 ± 3.83 | 4.46 (3.44 to 5.49)* |
Vivax malaria | |||
Number | 20 | 26 | |
Anti-malarial treatment | 1.41 ± 0.48 | 12.46 ± 2.72 | 11.05 (9.93 to 12.16)* |
Paracetamol | 0.003 ± 0.003 | 0.002 ± 0.002 | − 0.000 (− 0.002 to 0.001) |
Clinic visits | 5.12 ± 0.00 | 5.32 ± 1.04 | 0.20 (− 0.27 to 0.67) |
Total (usual care) | 7.41 ± 1.16 | 17.78 ± 3.20 | 10.38 (9.00 to 11.76)* |
Excess costs for trial | 54.72 ± 0.13 | 49.76 ± 0.43 | − 4.96 (− 5.16 to − 4.76)* |
Total (trial) | 62.12 ± 1.14 | 67.54 ± 3.45 | 5.42 (3.95 to 6.89)* |